Tomoregulin-2 is found extensively in plaques in Alzheimer's disease brain

Journal of Neurochemistry

Volumn 98, Issue 1, 2006, Pages 34-44

  Siegel, Donald A ^a   Davies, Peter ^b   Dobrenis, Kostantin ^b   Huang, May ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Neuritic plaques; Parkinson's disease; Tomoregulin 2

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; MEMBRANE PROTEIN; PRESENILIN 1; TOMOREGULIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL NUCLEUS; CELL SURFACE; CHROMOSOME 2Q; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DATA ANALYSIS; DENDRITE; DOPAMINERGIC SYSTEM; FEMALE; GENE LOCUS; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PLAQUE FORMING CELL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; CEREBRAL CORTEX; CLONING, MOLECULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; SENILE PLAQUES;

EID: 33745107526     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03801.x     Document Type: Article

References (47)

1. Afagh A. Cummings B. J. Cribbs D. H. Cotman C. W. Tenner A. J. ( 1996) Localization and cell association of C1q in Alzheimer's disease brain. Exp. Neurol. 138, 22 32.
2. Akiyama H. Barger S. Barnum S. Bradt B. et al. ( 2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383 421.
3. Amara F. M. Junaid A. Clough R. R. Liang B. ( 1999) TGF-beta(1), regulation of Alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization. Brain Res. Mol. Brain Res. 71, 42 49.
4. Amaratunga A. Fine R. E. ( 1995) Generation of amyloidogenic C-terminal fragments during rapid axonal transport in vivo of beta-amyloid precursor protein in the optic nerve. J. Biol. Chem. 270, 17 268 17 272.
5. Arai H. Lee V. M. Otvos L. Jr., Greenberg B. D. Lowery D. E. Sharma S. K. Schmidt M. L. Trojanowski J. Q. ( 1990) Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc. Natl Acad. Sci. USA 87, 2249 2253.
6. Benveniste E. N. Nguyen V. T. O'Keefe G. M. ( 2001) Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 39, 381 391.
7. Brendza R. P. Bacskai B. J. Cirrito J. R. et al. ( 2005) Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J. Clin. Invest. 115, 428 433.
8. Burton T. Liang B. Dibrov A. Amara F. ( 2002) Transcriptional activation and increase in expression of Alzheimer's beta-amyloid precursor protein gene is mediated by TGF-beta in normal human astrocytes. Biochem. Biophys. Res. Commun. 295, 702 712.
9. Cacquevel M. Lebeurrier N. Cheenne S. Vivien D. ( 2004) Cytokines in neuroinflammation and Alzheimer's disease. Curr. Drug Targets 5, 529 534.
10. Campion D. Dumanchin C. Hannequin D. et al. ( 1999) Early-Onset Autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet. 65, 664 670.
11. Chang C. Eggen B. J. Weinstein D. C. Brivanlou A. H. ( 2003) Regulation of nodal and BMP signaling by tomoregulin-1 (X7365) through novel mechanisms. Dev. Biol. 255, 1 11.
12. Chaudhury A. R. Gerecke K. M. Wyss J. M. Morgan D. G. Gordon M. N. Carroll S. L. ( 2003) Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 62, 42 54.
13. Culvenor J. G. McLean C. A. Cutt S. Campbell B. C. Maher F. Jakala P. Hartmann T. Beyreuther K. Masters C. L. Li Q. X. ( 1999) Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid. Am. J. Pathol. 155, 1173 1181.
14. Davies P. ( 1999) Characterization and use of monoclonal antibodies to tau and PHF-tau, in Methods in Molecular Medicine Alzheimer's Disease. Methods and Protocols ( Hooper N. A., ed.), pp. 361 374. Humana Press, Totowa.
15. Docagne F. Gabriel C. Lebeurrier N. Lesne S. Hommet Y. Plawinski L. Mackenzie E. T. Vivien D. ( 2004) Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription. Biochem. J. 383, 393 399.
16. Duff K. Knight H. Refolo L. M. et al. ( 2000) Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol. Dis. 7, 87 98.
17. Hardy J. Selkoe D. J. ( 2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353 356.
18. Harms P. W. Chang C. ( 2003) Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto. Genes Dev. 17, 2624 2629.
19. Haroutunian V. Perl D. P. Purohit D. P. Marin D. Khan K. LantZ. M. Davis K. L. Mohs R. C. ( 1998) Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch. Neurol. 55, 1185 1191.
20. Harris-White M. E. Chu T. Balverde Z. Sigel J. J. Flanders K. C. Frautschy S. A. ( 1998) Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures. J. Neurosci. 18, 10 366 10 374.
21. Hashimoto T. Wakabayashi T. Watanabe A. et al. ( 2002) CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV. EMBO J. 21, 1524 1534.
22. Horie M. Mitsumoto Y. Kyushiki H. et al. ( 2000) Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons. Genomics 67, 146 152.
23. Jamieson S. E. White J. K. Howson J. M. et al. ( 2005) Candidate gene association study of solute carrier family 11a members 1 (SLC11A1) and 2 (SLC11A2) genes in Alzheimer's disease. Neurosci. Lett. 374, 124 128.
24. Lahiri D. K. Chen D. Vivien D. Ge Y. W. Greig N. H. Rogers J. T. ( 2003) Role of cytokines in the gene expression of amyloid beta-protein precursor: identification of a 5′-UTR-binding nuclear factor and its implications in Alzheimer's disease. J. Alzheimers Dis. 5, 81 90.
25. Lesné S. Docagne F. Gabriel C. et al. ( 2003) Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J. Biol. Chem. 278, 18 408 18 418.
26. Lin H. Wada K. Yonezawa M. Shinoki K. Akamatsu T. Tsukui T. Sakamoto C. ( 2003) Tomoregulin ectodomain shedding by proinflammatory cytokines. Life Sci. 73, 1617 1627.
27. Mrak R. E. Griffin W. S. ( 2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26, 349 354.
28. Nishiyama E. Iwamoto N. Ohwada J. Arai H. ( 1997) Distribution of apolipoprotein E in senile plaques in brains with Alzheimer's disease: investigation with the confocal laser scan microscope. Brain Res. 750, 20 24.
29. Nussbaum R. L. Ellis C. E. ( 2003) Alzheimer's disease and Parkinson's disease. N. Eng.l J. Med. 348, 1356 1364.
30. Oddo S. Billings L. Kesslak J. P. Cribbs D. H. LaFerla F. M. ( 2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321 332.
31. Pankratz N. Nichols W. C. Uniacke S. K. Halter C. Murrell J. Rudolph A. Shults C. W. Conneally P. M. Foroud T. ( 2003a) Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Hum. Mol. Genet. 12, 2599 2608.
32. Pankratz N. Nichols W. C. Uniacke S. K. Halter C. Rudolph A. Shults C. Conneally P. M. Foroud T. ( 2003b) Significant linkage of Parkinson disease to chromosome 2q36-37. Am. J. Hum. Genet. 72, 1053 1057.
33. Robakis N. K. ( 1994) Beta-amyloid and amyloid precursor protein. chemistry, molecular biology and neuropathology, in Alzheimer's Disease ( Terry R. D. Katzman R. Bick K. L., eds), pp. 317 333. Lippincott-Raven, New York.
34. Schmidt M. L. Lee V. M. Trojanowski J. Q. ( 1991) Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads. Lab. Invest. 64, 352 357.
35. Selkoe D. J. ( 2001) Alzheimer's disease: genes, protein, and therapy. Physiol. Rev. 81, 741 766.
36. Siegel D. A. Huang M. K. Becker S. F. ( 2002) Ectopic dendrite initiation: CNS pathogenesis as a model of CNS development. Int. J. Dev. Neurosci. 20, 373 389.
37. Stokin G. B. Lillo C. Falzone T. L. et al. ( 2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282 1288.
38. Tanzi R. E. Bertram L. ( 2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545 555.
39. Tarkowski E. ( 2002) Cytokines in dementias. Curr. Drug Targets Inflamm. Allergy 1, 193 200.
40. Terry R. D. Masliah E. Hansen L. A. ( 1994) Structural basis of the cognitive alterations in Alzheimer disease, in Alzheimer's Disease ( Terry R. D. Katzman R. Bick K. L., eds), pp. 179 196. Lippincott-Raven, New York.
41. Tiraboschi P. Hansen L. A. Thal L. J. Corey-Bloom J. ( 2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62, 1984 1989.
42. Uchida T. Wada K. Akamatsu T. Yonezawa M. Noguchi H. Mizoguchi A. Kasuga M. Sakamoto C. ( 1999) A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem. Biophys. Res. Commun. 266, 593 602.
43. Wegiel J. Wang K. C. Imaki H. Rubenstein R. Wronska A. Osuchowski M. Lipinski W. J. Walker L. C. LeVine H. ( 2001) The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP (SW) mice. Neurobiol. Aging 22, 49 61.
44. Wyss-Coray T. ( 2004) Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration. J. Mol. Neurosci. 24, 149 153.
45. Yamaguchi H. Hirai S. Morimatsu M. Shoji M. Harigaya Y. ( 1988a) Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol. (Berl.) 77, 113 119.
46. Yamaguchi H. Hirai S. Morimatsu M. Shoji M. Ihara Y. ( 1988b) A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining. Acta Neuropathol. (Berl.) 76, 541 549.
47. Yamazaki T. Selkoe D. J. Koo E. H. ( 2001) Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J. Cell Biol. 129, 431 442.